Login
Cart
Support
Search
Search
×
Oncology Congress 2023
Search
Search
Search
Advanced Filters
Integrating PARP Inhibitors Into Treatment for Advanced Ovarian Cancer: Strategies for Improving Care and Outcomes
Date
April 1, 2023
Speakers
Robert L. Coleman
,
MD
Chief Scientific Officer
,
The US Oncology Network
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Navigating New Evidence in the Treatment of HER2-Expressing Metastatic Breast Cancer in Rural and Underserved Communities
Date
April 1, 2023
Speakers
Harold J. Burstein
,
MD, PhD
Medical Oncologist
,
Dana-Farber Cancer Institute
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
BREAK #1
Date
April 1, 2023
Navigating the Evolving Treatment Landscape of Renal Cell Carcinoma to Ensure Equitable Access to Quality Care
Date
April 1, 2023
Speakers
Martin H. Voss
,
MD
Clinical Director, Genitourinary Oncology Service
,
Memorial Sloan Kettering Cancer Center
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Integrating the Latest Evidence in Melanoma Care to Address Health Equity
Date
April 1, 2023
Speakers
Michael A. Davies
,
MD, PhD
Professor and Chair, Department of Melanoma Medical Oncology
,
University of Texas MD Anderson Cancer Center
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
BREAK #2
Date
April 1, 2023
Integrating the Latest Evidence on Management of Basal Cell Carcinoma: Improving Outcomes in Rural and Underserved Communities
Date
April 1, 2023
Speakers
David M. Miller
,
MD, PhD
Director, Center for Merkel Cell Carcinoma & Co-Director, NMSC Multidisciplinary Clinic
,
Massachusetts General Hospital Cancer Center
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma: Strategies for Improving Equitable and Timely Access to Care
Date
April 1, 2023
Speakers
David M. Miller
,
MD, PhD
Director, Center for Merkel Cell Carcinoma & Co-Director, NMSC Multidisciplinary Clinic
,
Massachusetts General Hospital Cancer Center
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
×
Evaluation